Peptides for Recovery Research: BPC-157, TB-500 and MOTS-c

Recovery-related peptide research covers a broad spectrum of biological processes: tissue repair, inflammation resolution, cellular energy metabolism, and musculoskeletal remodelling. Three peptides (BPC-157, TB-500, and MOTS-c) have emerged as among the most studied in these areas, each through distinct mechanisms.

BPC-157 (Body Protection Compound-157) is a synthetic 15-amino-acid peptide with a well-characterised preclinical profile in tissue repair models. Key mechanisms relevant to recovery research:

• VEGF upregulation, promotes angiogenesis at injury sites, improving blood supply to damaged tissue
• Tendon fibroblast proliferation, multiple rodent studies demonstrate accelerated tendon and ligament healing with BPC-157 treatment
• Nitric oxide modulation, BPC-157 influences NO signalling, which may support vasodilation and tissue perfusion
• Gut integrity, protective effects on intestinal mucosal barrier in inflammatory and NSAID-injury models

BPC-157 is of particular interest in musculoskeletal and gastrointestinal repair research. Its oral bioavailability in animal models (unusual for a peptide) has also generated interest in delivery route comparisons.

TB-500 is a synthetic analogue of Thymosin Beta-4, corresponding to its actin-binding region. Its research profile in recovery contexts includes:

• Actin sequestration (regulates G-actin availability, promoting cell motility and migration) processes fundamental to wound healing and tissue remodelling
• Anti-inflammatory signalling, reduces pro-inflammatory cytokine expression in preclinical models
• Cardiac muscle research, studies in models of cardiac injury suggest TB-500 may support cardiomyocyte survival and angiogenesis
• Systemic action, unlike BPC-157, TB-500 distributes systemically, making it of interest in research models where repair signals need to reach multiple sites

MOTS-c (Mitochondrial Open Reading Frame of the 12S rRNA-c) is a mitochondria-derived peptide encoded within the mitochondrial genome, a relatively recent discovery that has generated significant interest in metabolic and exercise research. Unlike BPC-157 and TB-500, which primarily target structural tissue repair, MOTS-c operates at the level of cellular energy metabolism:

• AMPK activation, MOTS-c activates AMPK (AMP-activated protein kinase), a master regulator of cellular energy homeostasis, promoting glucose uptake and fatty acid oxidation
• Insulin sensitivity, preclinical studies in aged and diet-induced obesity mouse models demonstrate MOTS-c improves insulin sensitivity and metabolic flexibility
• Exercise mimetic effects, MOTS-c levels rise in response to exercise in human studies; exogenous MOTS-c administration in aged mice partially recapitulates exercise adaptations
• Mitochondrial biogenesis, MOTS-c supports mitochondrial function and biogenesis, relevant to research on fatigue, exercise capacity, and metabolic recovery

The three peptides target recovery-relevant processes at different levels:

• BPC-157, local structural repair, angiogenesis, tendon/gut research
• TB-500, systemic cell migration, inflammation resolution, cardiac muscle research
• MOTS-c, mitochondrial energy metabolism, insulin sensitivity, metabolic recovery

This non-overlapping mechanistic profile makes them of interest to researchers studying multi-dimensional recovery models that involve both structural tissue repair and metabolic adaptation.

OzPeps supplies all three research-grade peptides Australia-wide:

• BPC-157 →
• TB-500 →
• MOTS-c →

All peptides supplied by OzPeps are for laboratory and in-vitro research purposes only. They are not TGA-approved therapeutic goods and are not intended for human or animal consumption.